Trials / Completed
CompletedNCT05714059
Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM
Safety and Effectiveness Evaluation of the MiniMed™ 780G System Used in Combination With the DS5 CGM
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 250 (actual)
- Sponsor
- Medtronic MiniMed, Inc. · Industry
- Sex
- All
- Age
- 7 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to confirm the safety and effectiveness of the MiniMed 780G insulin pump used in combination with the DS5 CGM in type 1 diabetes adult and pediatric subjects in a home setting.
Detailed description
This study is a multi-center, single arm study in insulin-requiring adult and pediatric subjects with type 1 diabetes on the MiniMed 780G system using DS5 as well as Medtronic Extended infusion set and reservoir. The run-in period and study period will be approximately 120 days long.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Insulin Pump with Continuous Glucose Monitoring | MiniMed™ 780G insulin pump in combination with the DS5 CGM |
Timeline
- Start date
- 2023-02-28
- Primary completion
- 2023-12-29
- Completion
- 2023-12-29
- First posted
- 2023-02-06
- Last updated
- 2025-02-17
- Results posted
- 2025-02-17
Locations
23 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05714059. Inclusion in this directory is not an endorsement.